InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.037

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$12 Immuron Appoints CEO Dr. Gary S. Jacob to Board of Directors 17 Apr 2019 9:29AM $0.240 $0.037 fallen by 84.58%
$12 Immuron releases new corporate slide deck presentation 16 Apr 2019 10:11AM $0.230 $0.037 fallen by 83.91%
$12 Immuron sales surge by 66% in the Third Quarter of FY19 15 Apr 2019 8:40AM $0.210 $0.037 fallen by 82.38%
$12 Change in substantial holding 12 Apr 2019 10:42AM $0.225 $0.037 fallen by 83.56%
$12 Immuron Aims to Secure FDA Approval for IMM-124E 11 Apr 2019 9:27AM $0.195 $0.037 fallen by 81.03%
$12 Supplementary Form F-3 9 Apr 2019 11:11AM $0.180 $0.037 fallen by 79.44%
$12 Form F-3 2 Apr 2019 10:02AM $0.205 $0.037 fallen by 81.95%
$12 Company Update on CDI Clinical Trial and New Strategic Focus 19 Mar 2019 9:16AM $0.230 $0.037 fallen by 83.91%
$12 Half Yearly Report and Accounts 28 Feb 2019 9:50AM $0.260 $0.037 fallen by 85.77%
$12 Travelan FY19 Update and Expansion into North America 29 Jan 2019 9:59AM $0.265 $0.037 fallen by 86.04%
$12 Form F-3 15 Jan 2019 9:46AM $0.270 $0.037 fallen by 86.30%
$12 Immuron Receives $1.19M R&D Tax Concession Refund 3 Jan 2019 9:40AM $0.210 $0.037 fallen by 82.38%
$12 Change in substantial holding 29 Nov 2018 11:46AM $0.255 $0.037 fallen by 85.49%
$12 Form 604 - Change in Substantial Shareholding (Grandlodge) 27 Nov 2018 10:25AM $0.240 $0.037 fallen by 84.58%
$12 Appendix 3Y - Change of Director's Interest Notice (PA) 27 Nov 2018 10:23AM $0.240 $0.037 fallen by 84.58%
$12 Appendix 3Y - Change of Director's Interest Notice (RJB) 27 Nov 2018 10:22AM $0.240 $0.037 fallen by 84.58%
$12 Appendix 3B 27 Nov 2018 10:20AM $0.240 $0.037 fallen by 84.58%
$12 NASH clinical trial presentation & continued revenue growth 9 Nov 2018 3:43PM $0.280 $0.037 fallen by 86.79%
$12 Annual Report 2018 on Form 20-F & XBRL data filed with SEC 1 Nov 2018 9:40AM $0.270 $0.037 fallen by 86.30%
$12 IMC's CEO Interviewed in US on the RedChip Money Report 16 Oct 2018 9:43AM $0.310 $0.037 fallen by 88.06%
$12 Notice of Annual General Meeting/Proxy Form 11 Oct 2018 8:54AM $0.295 $0.037 fallen by 87.46%
$12 Notice of Annual General Meeting/Proxy Form 10 Oct 2018 9:18AM $0.295 $0.037 fallen by 87.46%
$12 Corporate Governance Statement 27 Sep 2018 4:35PM $0.335 $0.037 fallen by 88.96%
$12 Appendix 4G 27 Sep 2018 4:34PM $0.335 $0.037 fallen by 88.96%
$12 Annual Report 27 Sep 2018 4:34PM $0.335 $0.037 fallen by 88.96%

476 - 500 of 790 results

Page 20 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.